Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Atezolizumab
Gliosarcoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
Atezolizumab
Large Cell Neuroendocrine Carcinoma
Phanes Therapeutics
P1/2
CC
(45)
Atezolizumab
Childhood Malignant Neoplasm
St. Jude Children's Research Hospital
P1/2
CC
(45)
Atezolizumab
Vulva Cancer
University of Florida
P1/2
CC
(45)
Atorvastatin
Thyroid Gland Papillary Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
Autologous Bcma/Cd19 Dual-Target Car-T Module
T-Lymphoblastic Lymphoma
Beijing Biotech
P1/2
CC
(45)
Autologous Cd33/Cll1 Dual-Target Car-T Module
T-Lymphoblastic Lymphoma
Beijing Biotech
P1/2
CC
(45)
Avelumab
Cutaneous Melanoma
Aulos Bioscience, Inc.
P1/2
CC
(45)
Avelumab
Gastroesophageal Cancer
Fate Therapeutics
P1/2
CC
(45)
Avelumab
Cholangiocarcinoma
National Cancer Institute (NCI)
P1/2
CC
(45)
Avelumab
Gallbladder Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(45)
Avelumab
Gallbladder Cancer
National Cancer Institute (NCI)
P1/2
CC
(45)
Avutometinib
Glioblastoma
Institute of Cancer Research, United Kingdom
P1/2
CC
(45)
Avutometinib
Malignant Glioma
Institute of Cancer Research, United Kingdom
P1/2
CC
(45)
Avzo-021
Hormone Receptor-Positive Breast Cancer
Avenzo Therapeutics, Inc.
P1/2
CC
(45)
Avzo-023
Hormone Receptor-Positive Breast Cancer
Avenzo Therapeutics, Inc.
P1/2
CC
(45)
Avzo-103
Urothelial Carcinoma
Avenzo Therapeutics, Inc.
P1/2
CC
(45)
Avzo-1418
Epithelial Neoplasm
Avenzo Therapeutics, Inc.
P1/2
CC
(45)
Avzo-1418
Urothelial Carcinoma
Avenzo Therapeutics, Inc.
P1/2
CC
(45)
Azacitidine
Chronic Neutrophilic Leukemia
M.D. Anderson Cancer Center
P1/2
CC
(45)
Azacitidine
Myelodysplastic Syndrome With Single Lineage Dysplasia
National Cancer Institute (NCI)
P1/2
CC
(45)
azd3470
Anaplastic Large Cell Lymphoma
AstraZeneca
P1/2
CC
(45)
azd4512
B-Cell Non-Hodgkin Lymphoma
AstraZeneca
P1/2
CC
(45)
azd6750
Cutaneous Neuroendocrine Carcinoma
AstraZeneca
P1/2
CC
(45)
azd8421
Ovarian Serous Adenocarcinoma
AstraZeneca
P1/2
CC
(45)
Showing 3401 to 3425 of 6,299 assets
Previous
Page 137 of 252
Next